Serum complement levels in immune thrombocytopenia: Characterization and relation to clinical features.

Complement levels are reduced in one-third of patients with ITP and are associated with more severe disease. Additional study is needed to evaluate if hypocomplementemia is predictive of response to emerging complement-directed therapies.